All posts by: Michael Zand

About Michael Zand

Rajni Kannan on Managing Patients on Combination Immunotherapy – Oncology Nursing News

Continue reading

2017-05-10 NEWS

Oncology Nursing News

Rajni Kannan on Managing Patients on Combination Immunotherapy
Oncology Nursing News
Rajni Kannan, BS, MS, RN, ANP-BC, of NYU Langone—Perlmutter Cancer Center—discusses the importance of keeping up with patients who have received combination immunotherapy. Combination immunotherapy can often have intense and quick-acting …

Continue reading

2017-05-10 NEWS

TheStreet.com

Merck Extends Immunotherapy Lead With Lung Cancer Combination Therapy Approval
TheStreet.com
FDA approvals of immunotherapies used alone to treat various cancers have become almost routine, but the agency’s latest affirmative nod to Merck marks the first time that an immunotherapy has been combined with another drug to kill cancer cells more …
US FDA approves Merck immunotherapy/chemo combo for lung cancerReuters
Merck boosted by FDA approval for Keytruda use with chemoFinancial Times

all 10 news articles »

Continue reading

2017-05-10 NEWS

Andrews Institute to conduct in stem cell study — 5 observations
Becker’s Orthopedic & Spine
Adam W. Anz, MD, of Gulf Breeze, Fla.-based Andrews Institute for Orthopaedic & Sports Medicine will lead a study evaluating stem cells‘ impact on regenerating knee cartilage with Dr. Khay Yong Saw of Malaysia-based Kuala Lumpur Sports Medicine …